Zobrazeno 1 - 10 of 348 pro vyhledávání: '"M Alan, Brookhart"'
1
Akademický článek
Can Patient-Reported Outcomes Measurement Information System estimate high-impact chronic pain after total shoulder arthroplasty?
Autor: Katherine S. Norman, PT, DPT, MS, M. Alan Brookhart, PhD, Oke Anakwenze, MD, MBA, Michael P. Bolognesi, MD, Maggie E. Horn, DPT, MPH, PhD, Adam P. Goode, PT, DPT, PhD, Steven Z. George, PT, PhD
Publikováno v: JSES International, Vol 8, Iss 6, Pp 1221-1227 (2024)
Background: Identification of high-impact chronic pain (HICP) among patients receiving total shoulder arthroplasty (TSA) may allow for the design and implementation of tailored pain interventions to address the negative impact on postoperative outcom
Externí odkaz: https://doaj.org/article/33d6b2633b6f4d1fa8b5ccbf57df6cb5
Zobrazit plný text záznamu
2
Akademický článek
A Retrospective, Longitudinal Registry Study on the Long-Term Durability of Ivacaftor Treatment in People with Cystic Fibrosis
Autor: Christian Merlo, Teja Thorat, Lisa J. McGarry, Christina V. Scirica, Maral DerSarkissian, Catherine Nguyen, Yuqian M. Gu, Aruna Muthukumar, Joe Healy, Jaime L. Rubin, M. Alan Brookhart
Publikováno v: Pulmonary Therapy, Vol 10, Iss 4, Pp 483-494 (2024)
Abstract Introduction Ivacaftor (IVA) has been shown to change the trajectory of cystic fibrosis (CF) disease progression by slowing the rate of lung function decline in clinical studies. Long-term real-world data help to confirm the durability of th
Externí odkaz: https://doaj.org/article/87a5f56fc12f4e5c98c0384be3eeadd6
Zobrazit plný text záznamu
3
Akademický článek
Cardiovascular Safety in Postmenopausal Women and Men With Osteoporosis Treated With Denosumab and Zoledronic Acid: A Post‐Authorization Safety Study
Autor: Leslie Spangler, Carrie M. Nielson, M. Alan Brookhart, Rohini K. Hernandez, Robert Kees Stad, Tzu‐Chieh Lin
Publikováno v: JBMR Plus, Vol 7, Iss 10, Pp n/a-n/a (2023)
Abstract Osteoporosis and cardiovascular disease are common in older adults. Treatment of osteoporosis reduces the burden of debilitating fractures; however, it is important to understand the benefit versus risk of treatment. This study evaluates the
Externí odkaz: https://doaj.org/article/129cec94551548f8a9a3a4343cd3a9c5
Zobrazit plný text záznamu
4
Akademický článek
QT-Prolonging Antibiotics, Serum-to-Dialysate Potassium Gradient, and Risk of Sudden Cardiac Death Among Patients Receiving Maintenance HemodialysisPlain Language Summary
Autor: Patrick H. Pun, Magdalene M. Assimon, Lily Wang, Sana M. Al-Khatib, M. Alan Brookhart, David J. Weber, Wolfgang C. Winkelmayer, Jennifer E. Flythe
Publikováno v: Kidney Medicine, Vol 5, Iss 5, Pp 100618- (2023)
Rationale & Objective: Treatment with certain QT interval-prolonging antibiotics is associated with a higher risk of sudden cardiac death among individuals with hemodialysis-dependent kidney failure. Concurrent exposure to large serum-to-dialysate po
Externí odkaz: https://doaj.org/article/50ba1410b514491eb1e7735e4a9ba997
Zobrazit plný text záznamu
7
Akademický článek
Use of Low‐Density Lipoprotein–Lowering Therapies Before and After PCSK9 Inhibitor Initiation
Autor: Jennifer A. Rymer, Katherine E. Mues, Keri L. Monda, Emily W. Bratton, Heidi S. Wirtz, Ted Okerson, Robert A. Overman, M. Alan Brookhart, Paul Muntner, Tracy Y. Wang
Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 9 (2020)
Background Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) are used to reduce low‐density lipoprotein (LDL) cholesterol. PCSK9i use after initiation, as well as persistence with or alterations to other LDL‐lowering therapy after
Externí odkaz: https://doaj.org/article/aada6edd7f1a471f9a160c2a92af5b56
Zobrazit plný text záznamu
8
External Comparator Groups Derived from Real-world Data Used in Support of Regulatory Decision Making: Use Cases and Challenges
Autor: Gillis Carrigan, Brian D. Bradbury, M. Alan Brookhart, William B. Capra, Victoria Chia, Kenneth J. Rothman, Khaled Sarsour, Michael D. Taylor, Jefferey S. Brown
Publikováno v: Current Epidemiology Reports. 9:326-337
Real-world data (RWD) from electronic health records (EHRs) and administrative claims databases are used increasingly to generate real-world evidence (RWE). RWE is used to support clinical evidence packages for medicines that inform decision-makers.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::47f1f70717078e4789d131995c7ce3f6
https://doi.org/10.1007/s40471-022-00305-9
Zobrazit plný text záznamu
9
Akademický článek
Timing of renal replacement therapy and long-term risk of chronic kidney disease and death in intensive care patients with acute kidney injury
Autor: Søren Christiansen, Steffen Christensen, Lars Pedersen, Henrik Gammelager, J. Bradley Layton, M. Alan Brookhart, Christian Fynbo Christiansen
Publikováno v: Critical Care, Vol 21, Iss 1, Pp 1-9 (2017)
Abstract Background The optimal time to initiate renal replacement therapy (RRT) in intensive care unit (ICU) patients with acute kidney injury (AKI) is unclear. We examined the impact of early RRT on long-term mortality, risk of chronic kidney disea
Externí odkaz: https://doaj.org/article/0b33a932db894254ac047847a1623efa
Zobrazit plný text záznamu
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje